What Is Cryptosporidium in Humans
Cryptosporidium is a microscopic parasite that infects the intestines of humans and causes cryptosporidiosis. The most common species linked to human illness are Cryptosporidium hominis and Cryptosporidium parvum. Infection typically results in watery diarrhea, stomach cramps, nausea, vomiting, and low-grade fever, with symptoms appearing 2 to 10 days after exposure. For most healthy adults, the illness is self-limiting and resolves within 1 to 2 weeks, but it can become chronic and severe in people with weakened immune systems, such as those with HIV/AIDS or organ transplants. According to the CDC, cryptosporidiosis is one of the leading causes of waterborne disease in the United States, and the parasite is resistant to standard chlorine disinfection used in many swimming pools and water treatment facilities CDC Cryptosporidiosis Page.
The parasite spreads through the fecal-oral route, meaning ingestion of as few as 10 oocysts can cause infection. Common transmission pathways include swallowing contaminated recreational water in pools, splash pads, and lakes, consuming contaminated food or unpasteurized milk, and direct contact with infected people or animals. Outbreaks frequently occur in childcare settings, daycare centers, and households due to poor hand hygiene. In immunocompromised individuals, the infection can spread to the biliary tract and lungs, leading to severe, life-threatening complications. The oocysts are immediately infectious when shed in stool and can survive for months in moist environments, making environmental contamination a persistent public health challenge WHO Cryptosporidiosis Fact Sheet.
Diagnosis, Treatment, and Prevention of Cryptosporidium in Humans
Diagnosis is confirmed through stool testing, with the modified acid-fast stain, immunofluorescence assay, or PCR-based molecular tests used to detect Cryptosporidium oocysts. Because the parasite can be shed intermittently, multiple stool samples collected on different days may be required for accurate detection. In the United States, cryptosporidiosis is a nationally notifiable condition, and laboratories must report confirmed cases to public health authorities to support outbreak tracking. For healthy individuals, treatment focuses on supportive care, including oral rehydration to prevent dehydration and electrolyte replacement. Antidiarrheal medications may relieve symptoms but do not shorten the duration of infection Mayo Clinic Cryptosporidiosis Overview.
For immunocompromised patients, nitazoxanide is the only FDA-approved antiparasitic treatment, though its efficacy is reduced in severely immune-suppressed individuals. In HIV/AIDS patients, restoration of immune function through antiretroviral therapy is the most effective long-term strategy for controlling chronic cryptosporidiosis. Prevention relies on strict hygiene practices, including thorough handwashing with soap and water after using the toilet, changing diapers, and before handling food. Boiling water for at least one minute, using NSF-certified filters with an absolute pore size of 1 micron or smaller, and avoiding swallowing untreated recreational water are key protective measures. Public health agencies also recommend that people with active diarrhea avoid swimming in public pools and that childcare facilities enforce rigorous surface disinfection protocols EPA Cryptosporidium in Drinking Water.
Global Impact and Recent Outbreak Trends of Cryptosporidium in Humans
Cryptosporidium causes an estimated 48,000 illnesses and